Hilterapia® and hand arthropathy from systemic lupus erythematosus: a new study

07 August 2020 - Research -
Share

A recent study - “Efficacy of high-intensity laser therapy on arthropathy of the hands in patients with systemic lupus erythematosus: a double-blinded, randomized controlled trial” – conducted on a sample of 50 patients affected by systemic lupus erythematosus with arthropathy to the hands confirms the efficacy of treatment with Hilterapia®.

Divided into two equally numbered groups, the patients (women between 30 and 50) respectively underwent Hilterapia® therapy combined with routine therapy (heat therapy, stretching and reinforcing exercises) and placebo laser with a similar routine program. After three sessions every 7 days for a total of 8 weeks, statistically significant differences were seen in grip strength, swelling, joint pain and VAS in favour of the group treated with Hilterapia®.

In conclusion, the addition of Hilterapia® to the routine therapeutic program can lead to a more effective improvement of the assessed parameters for patients with arthropathy to the hands compared with the routine therapeutic program on its own.

You might also be interested in ...

See all articles

Benefici laserterapia negli infortuni sportivi
blog - 12/02/2019
Laser Therapy influences In the medical field, laser is used for surgical (laser surgery) and therapeutic (laser therapy) applications. In particular, laser therapy is a physical therapy which can...
news - 30/01/2019
“Effect of a physiotherapy rehabilitation program on knee osteoarthritis in patients with different pain intensities”: this is the title of the research which aimed to examine the effects of a...
Efficacy of HILT on arthropathy of the hands
Research
N.M. Abdel-Aal, K.M. Ali, H.M. Eladl  Clinical Rehabilitation, Jul 8:269215520941059. doi: 10.1177/0269215520941059, 2020 Objective: To determine the efficacy of high-intensity laser therapy (...
ASA Partners Meeting 2024
News - 21/03/2024
Four days of full immersion in the world of ASA to focus on the new devices - M-Hi and HIRO – and to analyse the biological effects of Hilterapia®.
ASAlaser @ FIF Milano 2024
News - 19/03/2024
Not only top-of-the-line devices, including the new HIRO and M-Hi as well as Magneto Qs and M8, but also three workshops aimed at highlighting the strengths of its therapies.
ASA tema @ ArabHealth 2024
News - 15/02/2024
In order to provide maximum visibility and the best dissemination of the strengths of its Therapeutic Solutions, the company preceded its attendance at the fair (Dubai, 29th January – 1st February)...